Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.080
-0.130 (-3.09%)
At close: Oct 29, 2024, 4:00 PM
4.040
-0.040 (-0.98%)
After-hours: Oct 29, 2024, 6:12 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $519.41 million as of October 29, 2024. Its market cap has decreased by -23.74% in one year.
Market Cap
519.41M
Enterprise Value
398.13M
1-Year Change
-23.74%
Ranking
Category
Stock Price
$4.08
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $519.41M, a decrease of -68.08%. That is a compound annual growth rate of -43.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2024 | 489.70M | -43.21% |
| Dec 29, 2023 | 862.30M | -52.26% |
| Dec 30, 2022 | 1.81B | 10.98% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 544.68M |
| Community Health Systems | 542.82M |
| Corvus Pharmaceuticals | 540.44M |
| Surmodics | 539.29M |
| Varex Imaging | 537.32M |
| Cartesian Therapeutics | 532.89M |
| Arcturus Therapeutics Holdings | 529.22M |
| KalVista Pharmaceuticals | 522.48M |